Pfm Health Sciences, LP Mirati Therapeutics, Inc. Transaction History

Pfm Health Sciences, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $11.7 Million - $17.3 Million	318,948 New	318,948 $11.9 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $23.9 Million - $47.6 Million	-315,449 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $1.97 Million - $2.84 Million	14,904 Added 4.96%	315,449 $46.3 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $1.78 Million - $2.4 Million	13,499 Added 4.7%	300,545 $53.2 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $3.27 Million - $4.09 Million	-22,734 Reduced 7.34%	287,046 $46.4 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $16 Million - $22.3 Million	100,774 Added 48.22%	309,780 $53.1 Million
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $6.49 Million - $9.63 Million	-40,062 Reduced 16.08%	209,006 $45.9 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $28.2 Million - $41.7 Million	249,068 New	249,068 $41.4 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $30.5 Million - $55.6 Million	-431,123 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $33.6 Million - $47.3 Million	431,123 New	431,123 $33.6 Million
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $7.15 Million - $12.6 Million	-120,166 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $5.25 Million - $9.49 Million	120,166 New	120,166 $8.81 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.